HealthcareServices

Immunogenomics Market Size and Growth Forecast for Businesses 2025–2029

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Immunogenomics Market Covering 2025–2034?

The immunogenomics market has seen significant growth in recent years. Its valuation is expected to increase from $5.24 billion in 2024 to $6.09 billion in 2025, achieving a compound annual growth rate (CAGR) of 16.3%. The market’s previous expansion can be attributed to several factors, including the rising incidence of autoimmune conditions, an increasing need for personalized medical approaches, greater recognition of immunogenomic testing, governmental investment in healthcare research, and the development of the biotechnology and pharmaceutical industries.

The immunogenomics market size is projected to experience significant growth over the next few years. It is expected to reach $11.00 billion by 2029, expanding at a compound annual growth rate (CAGR) of 15.9%. This projected growth in the forecast period is primarily fueled by the increasing adoption of immunogenomic-based therapies, the expansion of precision medicine initiatives, rising investment in research and development, the broadening of healthcare infrastructure, and a growing demand for diagnostics. Notable trends anticipated in the forecast period include technological advancements in sequencing and genotyping, innovations in immunogenomic assays, developments in bioinformatics and data analysis, intensified research and development in targeted therapies, and the integration of artificial intelligence within immunogenomics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28247&type=smp

What Are The Key Drivers Of Growth In The Immunogenomics Market?

The expanding occurrence of infectious diseases is anticipated to fuel the expansion of the immunogenomics market. These diseases are conditions resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can be transmitted between individuals, either directly or indirectly. The growing incidence of infectious diseases stems from enhanced global travel, which allows pathogens to disseminate quickly across different regions. Immunogenomics improves the management of infectious diseases through precise examination of host immune reactions and genetic predispositions. This field minimizes trial-and-error approaches in therapy by pinpointing immune factors specific to each patient, thereby advancing diagnostics, vaccine creation, and tailored therapeutic plans. As an illustration, the UK Health Security Agency, a UK-based government body, reported in February 2024 that instances of tuberculosis, a highly contagious bacterial lung infection, in England climbed to 4,850 in 2023, marking a 10.7% rise from 4,380 cases recorded in 2022. Consequently, the expanding occurrence of infectious diseases is a key driver for the growth of the immunogenomics market.

What Are The Primary Types Of Segments Analyzed In The Immunogenomics Market?

The immunogenomics market covered in this report is segmented as

1) By Product Type: Instruments, Consumables, Software, Services

2) By Technology: Next-Generation Sequencing, Microarray, Polymerase Chain Reaction, Other Technologies

3) By Application: Oncology, Infectious Diseases, Autoimmune Disorders, Transplantation, Other Applications

4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Instruments: Sequencers, Microarray scanners, Flow cytometers

2) By Consumables: Reagents, Kits, Assay panels

3) By Software: Data analysis software, Bioinformatics tools, Visualization platforms

4) By Services: Sequencing services, Genomic profiling, Bioinformatics support

What Long-Term Trends Will Shape The Future Growth Of The Immunogenomics Industry?

Major companies operating in the immunogenomics market are concentrating on developing advanced solutions, such as single-cell transcriptome solutions, to enable precise analysis of immune cell diversity and improve the understanding of complex immune responses. A single-cell transcriptome solution denotes a technology or method that scrutinizes the complete set of RNA transcripts in individual cells, offering insights into gene expression patterns and cellular variations within intricate tissues. For instance, in October 2022, Pacific Biosciences of California Inc., a US-based biotechnology company, partnered with Broad Institute of MIT and Harvard, a UK-based biomedical and genomic research center, and 10x Genomics Inc., a US-based biotechnology company, to launch a Multiplexed Arrays Sequencing (MAS-Seq) kit. This kit aims to enable high-throughput, cost-effective sequencing of full-length transcripts. It provides an economical, high-volume, full-length, single-cell transcriptome solution, identifying novel RNA isoforms and mutations with exceptional accuracy. The solution increases sequencing throughput by 16-fold through the concatenation of cDNA molecules and integrates seamlessly with 10x Genomics single-cell technology and PacBio sequencers. This capability empowers researchers to explore cellular heterogeneity at the isoform level, advancing disease research and biomarker discovery.

Who Are The Top Performing Companies In The Immunogenomics Market In Recent Years?

Major companies operating in the immunogenomics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Illumina Inc., BGI Group, GenScript Biotech Corporation, CareDx Inc., Oxford Nanopore Technologies plc, Genewiz LLC, Adaptive Biotechnologies Corporation, GenomOncology LLC, Personalis Inc., Variantyx Inc., CD Genomics Inc., Sengenics Corporation, GeneCentric Therapeutics Inc., Immunogenomics Inc., ImmuQuad Biotechnologies Inc., Neomics Pharmaceuticals LLC, Yemaachi Biotech Ltd., and BioAnalytica Biotechnology Systems Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/immunogenomics-global-market-report

How Do Regional Market Performances Compare Within The Immunogenomics Industry?

North America was the largest region in the immunogenomics market in 2024. The regions covered in immunogenomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Immunogenomics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28247&type=smp

Browse Through More Reports Similar to the Global Immunogenomics Market 2025, By The Business Research Company

Immunohematology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoassay Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Automated Immunoassay Analyzers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automated-immunoassay-analyzers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795